MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹2,515 Cr | ₹190,193 Cr | ₹1,991 Cr | ₹165 Cr | ₹14,447 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
Year | Operating Profit |
---|---|
Mar2025 | ₹2,515 Cr |
Mar2024 | ₹190,193 Cr |
Mar2023 | ₹1,991 Cr |
Mar2022 | ₹165 Cr |
Mar2021 | ₹14,447 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹2,515 Cr | -98.68 | |
Mar2024 | ₹190,193 Cr | 9,454.83 | |
Mar2023 | ₹1,991 Cr | 1,107.04 | |
Mar2022 | ₹165 Cr | -98.86 | |
Mar2021 | ₹14,447 Cr | - |
Compare Operating Profit of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹102,432.2 Cr | -4.4% | 0.3% | -7.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹380,666.0 Cr | -3.5% | 0% | -12.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,060.0 Cr | -6.6% | -7.2% | 9.8% | Stock Analytics | |
CIPLA | ₹121,080.0 Cr | -2.8% | -5% | -7.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,605.0 Cr | -2.5% | -0.4% | 1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,556.0 Cr | -3.8% | -0.6% | -4.2% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | -4.4% |
0.3% |
-7.7% |
SENSEX | -2.7% |
-0.5% |
-5.3% |
You may also like the below Video Courses